Development of a continuous genome shuffling approach to expedite adaptive laboratory evolution
开发连续基因组改组方法以加速适应性实验室进化
基本信息
- 批准号:1605347
- 负责人:
- 金额:$ 35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Standard Grant
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-07-01 至 2020-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
1605347Kao, Katy C.This project will develop a novel methodology to study how microbes evolve. All biological systems have the capacity to adapt and to evolve. Adaptive evolution can be used as a tool for the development of effective strains for the conversion of renewable feedstock to fuels and chemicals for a more sustainable route of production. Due to the complexity of biological systems, the process of how microbes adapt and evolve is not fully understood. The researchers will address this challenge by developing a strain of Escherichia coli that can be used to expedite the process of adaptive evolution via the continuous recombination of beneficial mutations while removing neutral or deleterious mutations from the population. The tools to be developed in the proposed work can also be applied to gain fundamental understandings of the emergence and development of antibiotic drug resistance. The ability of biological systems to adapt and evolve is both an advantage and disadvantage in the field of biotechnology. This evolutionary potential of microbial systems presents opportunities for developing strains with desired traits. On the other hand, undesired adaptation can cause strain instability and loss of performance. The goal of this project is to address this limitation by developing an enabling methodology towards the fundamental study of evolutionary processes in microbial systems. Adaptive laboratory evolution (ALE) is a powerful inverse engineering tool that can be used to generate microbes with desired traits and to uncover the underlying mechanisms of how microbes evolve and adapt. Specifically, this project aims to develop a continuous in situ genome shuffling system that expedites ALE experiments in Escherichia coli, which will allow beneficial mutations from different clones to recombine to form superior genotypes and deleterious mutations to be removed from an otherwise superior strain. Therefore, the overarching hypothesis of the proposed work is that inclusion of sexual recombination will expedite the rate of adaptive evolution. This hypothesis will be tested via three objectives: (i) characterization of the benefit of an efficient bi-directional conjugation system in E. coli, (ii) development of a conditional mutator version of the genderless system, and (iii) application of the system to develop E. coli strains that exhibit multiple desired characteristics and that elucidate the impacts of adaptive evolutionary strategies and recombination on the rates of adaptation, evolutionary trajectories, and mechanisms of adaptation. The work will involve team members from engineering and plant pathology and microbiology, allowing students at all levels to gain experience in interdisciplinary research.This award by the Biotechnology and Biochemical Engineering Program of the CBET Division is co-funded by the Genetic Mechanisms Program of the Division of Molecular and Cellular Biosciences.
1605347高,凯蒂C.该项目将开发一种新的方法来研究微生物如何进化。 所有生物系统都有适应和进化的能力。 适应性进化可用作开发有效菌株的工具,用于将可再生原料转化为燃料和化学品,以实现更可持续的生产途径。 由于生物系统的复杂性,微生物如何适应和进化的过程尚未完全了解。 研究人员将通过开发一种大肠杆菌菌株来应对这一挑战,该菌株可用于通过有益突变的连续重组来加速适应性进化过程,同时从种群中去除中性或有害突变。 在拟议的工作中开发的工具也可以应用于获得抗生素耐药性的出现和发展的基本理解。 生物系统适应和进化的能力在生物技术领域既是优势,也是劣势。 微生物系统的这种进化潜力为开发具有所需性状的菌株提供了机会。 另一方面,不期望的适应可能导致应变不稳定和性能损失。该项目的目标是通过开发一种对微生物系统进化过程进行基础研究的方法来解决这一限制。 适应性实验室进化(ALE)是一种强大的逆向工程工具,可用于产生具有所需性状的微生物,并揭示微生物如何进化和适应的潜在机制。 具体而言,该项目旨在开发一种连续的原位基因组改组系统,加速大肠杆菌中的ALE实验,这将允许来自不同克隆的有益突变重组以形成上级基因型,并从其他上级菌株中去除有害突变。 因此,这项工作的首要假设是,包括性重组将加快适应性进化的速度。 这一假设将通过三个目标进行测试:(i)在大肠杆菌中有效的双向缀合系统的益处的表征。大肠杆菌,(ii)开发无性别系统的条件突变子版本,以及(iii)应用该系统开发大肠杆菌。大肠杆菌菌株表现出多种所需的特性,并阐明适应性进化策略和重组对适应率,进化轨迹和适应机制的影响。 这项工作将涉及来自工程和植物病理学和微生物学的团队成员,让各级学生获得跨学科研究的经验。该奖项由CBET部门的生物技术和生物化学工程项目共同资助,由分子和细胞生物科学部门的遗传机制项目共同资助。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Arul Jayaraman其他文献
Flavonoids: structure–function and mechanisms of action and opportunities for drug development
- DOI:
10.1007/s43188-020-00080-z - 发表时间:
2021-01-20 - 期刊:
- 影响因子:2.300
- 作者:
Stephen Safe;Arul Jayaraman;Robert S. Chapkin;Marcell Howard;Kumaravel Mohankumar;Rupesh Shrestha - 通讯作者:
Rupesh Shrestha
Uniform sized cancer spheroids production using hydrogel-based droplet microfluidics: a review
- DOI:
10.1007/s10544-024-00712-3 - 发表时间:
2024-05-29 - 期刊:
- 影响因子:3.300
- 作者:
Sungjin Kim;Po Yi Lam;Arul Jayaraman;Arum Han - 通讯作者:
Arum Han
Arul Jayaraman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Arul Jayaraman', 18)}}的其他基金
Collaborative Research: Identification of Immunomodulatory Microbiota Metabolites
合作研究:免疫调节微生物代谢物的鉴定
- 批准号:
1264526 - 财政年份:2013
- 资助金额:
$ 35万 - 项目类别:
Standard Grant
CAREER: Inter-kingdom Signaling as a Paradigm for Molecular Systems Biology
职业:王国间信号传导作为分子系统生物学的范例
- 批准号:
0846453 - 财政年份:2009
- 资助金额:
$ 35万 - 项目类别:
Standard Grant
CDI-Type II: Extracting Population and Stochastic Effects on Signaling Activity from Transcription Factor Profiles
CDI-Type II:从转录因子谱中提取群体和对信号活动的随机效应
- 批准号:
0941313 - 财政年份:2009
- 资助金额:
$ 35万 - 项目类别:
Standard Grant
Collaborative Research: Real-time Profiling of Regulatory Molecule Network in Adipocytes
合作研究:脂肪细胞调节分子网络的实时分析
- 批准号:
0651864 - 财政年份:2007
- 资助金额:
$ 35万 - 项目类别:
Standard Grant
相似国自然基金
高频数据波动率统计推断、预测与应用
- 批准号:71971118
- 批准年份:2019
- 资助金额:50.0 万元
- 项目类别:面上项目
星载连续波合成孔径雷达信号处理方法研究
- 批准号:61172122
- 批准年份:2011
- 资助金额:55.0 万元
- 项目类别:面上项目
连续化悬浮燃烧合成硅基陶瓷粉体的应用基础研究
- 批准号:50372074
- 批准年份:2003
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
Shaping Next Generation Aminoglycoside Antibiotics for Treatment of Multidrug-Resistant Diseases
打造下一代氨基糖苷类抗生素治疗多重耐药性疾病
- 批准号:
10585038 - 财政年份:2023
- 资助金额:
$ 35万 - 项目类别:
Collaborative Research: Deciphering complex phenotypes in bacteria aided by continuous genome shuffling and high throughput analytical technologies
合作研究:借助连续基因组改组和高通量分析技术破译细菌中的复杂表型
- 批准号:
2114188 - 财政年份:2022
- 资助金额:
$ 35万 - 项目类别:
Standard Grant
Examining a mechanism for insulin resistance in short sleeping adolescents: Melatonin, food intake, and the role of a melatonin receptor gene variant (MTNR1B)
检查睡眠不足的青少年的胰岛素抵抗机制:褪黑激素、食物摄入和褪黑激素受体基因变异 (MTNR1B) 的作用
- 批准号:
10701803 - 财政年份:2022
- 资助金额:
$ 35万 - 项目类别:
Collaborative Research: Deciphering complex phenotypes in bacteria aided by continuous genome shuffling and high throughput analytical technologies
合作研究:借助连续基因组改组和高通量分析技术破译细菌中的复杂表型
- 批准号:
2114203 - 财政年份:2022
- 资助金额:
$ 35万 - 项目类别:
Standard Grant
Continuous Evolution of Proteins with Novel Therapeutic Potential
具有新治疗潜力的蛋白质的不断进化
- 批准号:
10181559 - 财政年份:2021
- 资助金额:
$ 35万 - 项目类别:
Continuous Evolution of Proteins with Novel Therapeutic Potential
具有新治疗潜力的蛋白质的不断进化
- 批准号:
10588186 - 财政年份:2021
- 资助金额:
$ 35万 - 项目类别:
Pharmacogenetic discovery in the GRADE comparative effectiveness type 2 diabetes clinical trial
GRADE 2 型糖尿病有效性比较临床试验中的药物遗传学发现
- 批准号:
10589095 - 财政年份:2021
- 资助金额:
$ 35万 - 项目类别:
Continuous Evolution of Proteins with Novel Therapeutic Potential
具有新治疗潜力的蛋白质的不断进化
- 批准号:
10393666 - 财政年份:2021
- 资助金额:
$ 35万 - 项目类别: